PharmaLive > FDA/Regulatory > Drug Enforcement Administration (DEA) > Trump administration seeks cuts in production of abused opioids
Trump administration seeks cuts in production of abused opioids
WASHINGTON (Reuters) – The Trump administration on Thursday said it was proposing that U.S. pharmaceutical companies cut production of the six most abused opioids by 10 percent next year.
In a joint statement, the U.S. Justice Department and Drug Enforcement Administration said the proposed reduction would be in keeping with President Donald Trump’s effort to cut opioid prescription fills by one-third within three years.
Reporting by Tim Ahmann; Editing by Chizu Nomiyama
Reuters source:
Ad Right Top
MedAdNews
Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.
February 2019 Focus: Agenda 2019, Top 10 Pipelines To Watch, Value Of Pharmaceuticals, and more!